FDA's Legislative Request on Rx and Compounded Drug Advertising Coalition for Healthcare Communication Restoring Balance: What the FDA's Peptide Announcement Could Mean for Patient Access and Safety Empower Pharmacy People are turning themselves into lab rats': the injectable peptides craze sweeping the US Well actually The Guardian BPC 157: Miracle Healing Peptide or Hidden Danger? The FDA has issued warning letters to multiple companies marketing compounded Retatrutide, an investigational drug from Eli Lilly still in Phase II trials. While early studies have shown promising weight loss results, Retatrutide